You are now leaving the Otrivin.me site and moving to an external website independently operated and not managed by GSK.

GSK assumes no responsibility for the site.

If you wish to leave the site, click 'continue'.

  • Middle East
    • English
    • Arabic

Font size  A A A

Healthcare professionals

  • Feel better
  • Symptoms
  • Our range

Site map

Feel Better

  • How do we breathe?
  • Spray vs. Pills - What is more effective?
  • Using the nasal spray
  • Drops vs. Spray - What are the differences?
  • What is xylometazoline?
  • How to get rid of a cold fast
  • How to treat sinusitis
  • How Otrivin can help treat sinusitis
  • How nasal sprays help
  • Sick kids? How Otrivin can help with colds in babies and children

Symptoms

  • Learn about how nasal congestion can make colds worse and what you can do

Our range

  • Otrivin 0.1% Metered Dose Nasal Spray
  • Otrivin Menthol 0.1% Metered Dose Nasal Spray
  • Otrivin Complete Nasal Spray
  • Otrivin 0.05% Pediatric Metered Dose Nasal Spray
  • Otribaby Nasal Aspirator
  • Otribaby Soft Nozzle Refills
  • Otrivin 0.1% Nasal Drops
  • Otrivin 0.05% Pediatric Nasal Drops
  • Otrisalin Metered Dose Nasal Spray
  • Otrisalin Metered Dose Nasal Spray
  • Otri Allergy Aqueous Nasal Spray
  • FAQs
  • Contact us

This website is intended for residents of Middle East only (except Saudi Arabia).
Use of this web site is subject to our Terms of Use.
Copyright 2019 the GSK group of companies or its licensor.
 All rights reserved.
LP4T5Q0G-111122
PM-BH-OTRI-21-00066
PM-BH-OTRI-21-00067
PM-BH-OTRIA-22-00002
PM-BH-OTRI-21-00057

GlaxoSmithKline plc. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.

  • Privacy Policy 
  • Cookie Policy
  • Terms of use
  • Accessibility
  • Sitemap
 
gsk small logo
  • Privacy Policy
  • Cookie Policy
  • Terms of use
  • Accessibility
  • Sitemap
Required
EnlargeReduce Conclude

This website is intended for residents of Middle East only. For reporting any adverse event/side effects related to any GSK product please contact us on 'contactus-me@gsk.com' or simply use the Contact Us button! Should symptoms persist consult your healthcare professional.
Small print
This website is intended for residents of Middle East only (except Saudi Arabia).
Use of this web site is subject to our Terms of Use.
Copyright 2018 the GSK group of companies or its licensor.
All rights reserved.
LP4T5Q0G-111122
PM-BH-OTRI-21-00066
PM-BH-OTRI-21-00067
PM-BH-OTRIA-22-00002
PM-BH-OTRI-21-00057
GlaxoSmithKline plc. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.
gsk small logo